“Such antibodies offer a novel, more selective and thus safer approach for treating ion-channel-related diseases,” he added. Antibodies are also more versatile than small mol-ecules—they can ...

Astrocytes — named for their star-like shape — are a type of brain cell as abundant as neurons in the central nervous system, ...

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development ...

This makes them promising targets for the development of new drugs to combat cancer, metabolic diseases, inflammation, and more. Researchers have been studying TRPM8 ion channels in order to ...

This makes them promising targets for the development of new drugs to combat cancer, metabolic diseases, inflammations, and more. Researchers have been studying TRPM8 ion channels in order to ...

US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease: Aarhus, Denmark Tuesday, January 7, 2025, 16:00 Hrs [IST] NMD Ph ...

Rasband's team is discovering the functional organization of axons in health as well as disease or injury. The generation, propagation, and modulation of electrical signals in the nervous system ...

NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease This is the 2nd ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--SiteOne Therapeutics, Inc., a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough, and other ...